 |
|
|
| |
Efficacy of Dolutegravir/Abacavir/Lamivudine (ABC/DTG/3TC) Fixed Dose Combination (FDC) compared with Ritonavir Boosted Atazanavir (ATV/r) plus Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC) in Treatment-Naïve Women with HIV-1 Infection (ARIA Study): Analyses by Race Subgroups
|
| |
| |
Reported by Jules Levin
IDWeek 2016 Oct 26-30 New Orleans
Debbie Hagins, MD1, Craig Dietz, MD2, Mamta Jain, MD3, Cornelius Van Dam, MD4, Indira Brar, MD5, Choy Man, BSc6, Jiangxiu Zhou, PhD7, Annie Buchanan, MD, MPH6, Brian Wynne, MD8, Cindy Vavro, BA6, Michael Aboud, MD9 and Kimberly Smith, MD6
|
| |
|
|
|
|
|
